Leading Element Driving Change in the Colorectal Cancer Screening Market in 2025: The Aging Population Drives Growth In Colorectal Cancer Screening Demand Driver

What Is the Estimated Market Size and Growth Rate for the Colorectal Cancer Screening Market?
In recent times, there has been a solid growth in the size of the colorectal cancer screening market. Projected to elevate from $15.61 billion in 2024 to a significant $16.6 billion in 2025, it is expected to register a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this growth trend in the historical period include an ascending prevalence of colorectal cancer, governmental promotion of awareness campaigns, an aging demographic, increased utilization of colonoscopy procedures, and enhanced insurance coverage policies.

In the approaching years, a significant increase is anticipated in the colorectal cancer screening market, expected to reach $21.01 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. This predicted growth can be connected to the transition towards non-invasive screening techniques, a rise in home-based tests, a surge in obesity rates, widespread adoption of value-based healthcare, and a growth in public-private collaborations. Key trends for the forecast period comprise the adoption of AI in screening and diagnosis, expanding testing guidelines to younger demographics, increased application of genomic testing for cancer susceptibility, a rise in mobile health (mHealth) solutions, and alliances between pharmaceutical and diagnostics firms.

What Are the Forces Behind the Rapid Growth of the Colorectal Cancer Screening Market?
The growth of the colorectal cancer screening market is anticipated to be driven by a rising aging populace. An aging population is a demographic progression characterized by an increase in the percentage of elderly individuals (usually 65 years and above) set against the working population, a phenomenon often attributable to extended life spans and receding birth rates. This demographic is on the rise due to with more people living longer and fewer babies being born, resulting in a larger segment of older adults within the worldwide population. It's crucial to have colorectal cancer screening as part of the healthcare management for this expanding group, as it allows early cancer detection and prevention, dealing effectively with the heightened cancer risk faced by elderly individuals and improving their overall health trajectory. For example, based on data released by the Population Reference Bureau (PRB), a non-profit research organization in the US, it is forecasted that the number of Americans aged 65 and above will jump from 58 million in 2022 to 82 million by 2050, a surge of 47%, and their slice of the total populace is projected to expand from 17% to 23%. Hence, the growth in the elderly population is a key catalyst propelling the colorectal cancer screening market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19008&type=smp

Who Are the Dominant Companies Influencing Colorectal Cancer Screening Market Trends?
Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

How Is the Colorectal Cancer Screening Market Evolving?
Major corporations involved in the colorectal cancer screening market are concentrating their efforts on creating groundbreaking solutions such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests. These novel solutions aim to provide an efficient, easy-to-access method for early detection of colorectal cancer, enhance patient prognosis, and promote wider participation in screening activities. Non-invasive multi-target stool RNA tests for colorectal cancer screening use RNA markers obtained from a stool sample to identify the existence of colorectal cancer or premalignant lesions, providing a non-surgical technique for early identification. For example, Geneoscopy Inc., a US-based biotechnology firm, received approval from the U.S. Food and Drug Administration (FDA) in May 2024 for ColoSense. This innovative technology uses RNA biomarkers for a non-invasive, stool-based screening that showed 93% sensitivity in diagnosing colorectal cancer and 45% sensitivity for advanced adenomas. The importance of ColoSense stems from its high precision, particularly in younger populations, and its capacity to boost screening rates by presenting a less invasive option compared to conventional methods.

What Are the Different Segmentations in the Colorectal Cancer Screening Market?
The colorectal cancer screeningmarket covered in this report is segmented -

1) By Type: Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
2) By Age Group: Below 50 Years, 50-64 Years, Above 65 Years
3) By End User: Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users

Subsegments:
1) By Stool-Based Tests: Stool-Based Tests
2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT, Low-Sensitivity FIT
3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT, Immunochemical FOBT
4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test, Single-Target Stool DNA Test
5) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy
6) By Other Types: Virtual Colonoscopy, Flexible Sigmoidoscopy, Capsule Endoscopy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-screening-global-market-report

Which Region Is at the Forefront of the Colorectal Cancer Screening Market?
North America was the largest region in the colorectal cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Colorectal Cancer Screening Global Market Report?

- Market Size Analysis: Analyze the Colorectal Cancer Screening Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Colorectal Cancer Screening Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Colorectal Cancer Screening Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Colorectal Cancer Screening Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19008

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.